Clinical Trial

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled Phase III trial was designed to evaluate the impact of supplemental vitamin D (VD) on the efficacy and side effects of neoadjuvant therapy in patients with breast cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-13.
Status change: Not Yet Recruiting → Recruiting 2025-01-16
Trial Details
NCT Number NCT06642428
Lead Sponsor Jiuda Zhao
Conditions Vitamin D, Neoadjuvant Therapy, Breast Cancer, Adverse Reaction, Efficacy, Chemotherapy
Enrollment 140 participants
Start Date 2024-10-18
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-17